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source for most antibiotics on the market today, including
the ﬁrst-line and salvage TB regimens, including rifampin,
streptomycin, amikacin and etc. A set of Microbial Natural
Product Library (MNPL) containing secondary metabolites
from a unique collection of actinomycetes and fungal
strains from un- or under-explored ecological niches in China
has been constructed. A pilot screen for potential anti-TB
compounds was conducted with a selection of 5,000 extracts
samples from this MNPL, utilizing a GFP labeled M. bovis
BCG based HTS model (Z’-factor 0.8, CV < 15%, throughput
60,000 wells/day). 80 out of the 5,000 extracts showed
>90% inhibition against logarithmically growing BCG were
further evaluated on M. tb H37Rv strains at Broad Institute,
as a dilution series ranging from 1× to 1/128×. The
results showed that 46 extracts demonstrated anti-H37Rv
activity, with 8 showing activity at 1/16×, and 1 showing
activity at 1/128×. The following large scale fermentation
and bioactivity guided compound isolation work lead to
the discovery of diversiﬁed class of anti-TB compounds,
including actinomycins (MIC 1 4 ug/ml), quinomycins (MIC
0.5 ug/ml), nanaomycins (MIC 8 ug/ml), cyclopeptides (MIC
2 8 ug/ml), anthraquinones (MIC 4 8 ug/ml), oligomycins,
part of which were new compounds (not listed).
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Objectives: Etambutol is one of ﬁrst-line antitubercular
drugs in current therapeutic regimens. Its main
disadvantage is wide spectrum of adverse effects which can
lead to therapeutic failure. The aim of present study was to
investigate etambutol effects on rat liver cytochrome P-450
isoforms expression and DNA-fragmentation processes.
Methods: Wistar albino male rats (160 200 g b.w.) were
divided into two groups: I received etambutol per os at a
dose of 155mg/kg b.w./day, II control. After 60 days of the
experiment, rats were sacriﬁced via cervical dislocation.
Expression of rat liver CYP2E1, CYP3A2 and CYP2C23
were studied by RT-PCR methods. DNA fragmentation was
investigated electrophoretically.
Results: Our data demonstrated etambutol-mediated
quantitative and qualitative changes in male rat DNA
fragmentation and expression of CYP2E1, CYP3A2 and
CYP2C23 in comparison with control. CYP2E1 and CYP3A2
expression increasing was accompanied with CYP2C23
expression inhibition. DNA fragmentation processes were
also greatly intensiﬁed at etambutol treatment. Its
introduction caused appearance of new fractions with
longer DNA-fragments (above 1000 b.p., 1000 800 b.p. and
800 600 b.p.). Among shorter DNA-fragments main fraction
contained chains with 20 30 b.p.
Conclusion: Thus etambutol treatment caused adverse
effects in organisms on the level of cytochrome P-450
isoforms expression and DNA-fragmentation processes.
Extensive investigation of etambutol and cytochrome P-450
system interactions allowed to prevent or correct this
antitubercular agent adverse effects.
OL-034 A comparison study of extrapulmonary and
pulmonary tuberculosis in Hong Kong
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Background: This study examines the differences between
culture positive extrapulmonary and pulmonary tuberculosis
(TB) patients. It correlates these ﬁndings with the current
understanding of extrapulmonary TB. It looks at how these
factors affect mortality at six months and at the role of
underlying diseases in drug resistance.
Method: This is a two year retrospective study comparing
115 extrapulmonary TB patients with 115 pulmonary TB
patients.
Results: Extrapulmonary patients were younger than
pulmonary patients with a median age of 53 years versus
73 years (p < 0.001). They presented more commonly
with lymphadenopathy (p < 0.001). More extrapulmonary
patients had chronic renal failure (p < 0.002) and Human
Immunodeﬁciency Virus (HIV) infection (p = 0.005). They had
a higher median erythrocyte sedimentation rate (61mm/h
vs. 48mm/h, p = 0.017), and lactate dehydrogenase level
(309U/L vs. 197U/L, p = 0.006). They had a lower median
hemoglobin (10.7 g/dL vs. 11.7 g/dL, p = 0.002), white
blood cell count (7.4×109/L vs. 8.5×109/L, p = 0.039), and
lymphocyte count (0.9×109/L vs. 1.1×109/L, p = 0.051).
There was no difference in mortality between
extrapulmonary and pulmonary groups. Multivariate
analysis identiﬁed age >60 years (Odds Ratio [OR] 2.4,
95% Conﬁdence interval [95%CI] 0.98 5.77, p = 0.054),
presentation with decreased general condition (OR 3.5,
95%CI 1.46 8.34, p = 0.005), hypertension (OR 2.7, 95%CI
1.16 6.38, p = 0.021), radiological old TB (OR 2.6, 95%CI
1.25 5.52, p = 0.014), and pleural effusion (OR 3.2, 95%CI
1.45 7.03, p = 0.004) as independent risk factors for
mortality.
9.1% of all cases had culture evidence of drug resistance. HIV
infection (p = 0.001) and intravenous drug usage (p = 0.001)
were the two risk factors identiﬁed.
Conclusion: There are important differences in
demographics, clinical presentation and risk factors for
extrapulmonary compared with pulmonary TB. Mortality is
related to age and co-morbidity.
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Objectives: Tuberculosis, MTB or TB is the seventh leading
frequent cause of death worldwide among infectious
diseases. It is important to evaluate the current burden
of disease, to know how this has been changing over time.
Method: Review of current literature.
Result: According to the WHO, an estimated about 9.2
million (139/100,000 population) new cases of TB occurred
in 2006. Of these cases, 4.1 million (62/100,000 population)
were new smear positive cases. There were 14.4 million
(219/100,000 population) prevalent cases. There are 22
high-burden countries, but the majority of patients with TB
live in the eight country of Asia; India, China, Indonesia,
Bangladesh, Pakistan, Philippines, Vietnam and Afghanistan.
India is the highest TB burden country in the world
and accounts for nearly one-ﬁfth (20%) of global burden
of tuberculosis. In India, TB affects adults in the most
productive age group (15 54 years). More than 80% of TB
cases are in this group. TB kills almost 0.37 million Indian
people every year with mortality rate of about 28/100,000
population. Globally, the case detection rate by DOTS
programs increased almost linearly from 11% in 1995 to 28%
in 2000, and then accelerated to 45% in 2003. The recent
acceleration has been mostly due to rapid implementation
in India, where case detection increased from 1.7% in 1998
to 47% in 2003, and in China, where it increased from 30% in
2002 to 43% in 2003. India and China together accounted for
Free Paper Presentation 5: Tuberculosis S27
63% of the increase in case notiﬁcation by DOTS programs
between 2002 and 2003.
Conclusions: Without DOTS and Public awareness program,
it is highly unlikely that countries will be able to
develop effective and sustainable tuberculosis program.
With the introduction of DOTS, achieving the global
targets for tuberculosis control has now become a realistic
proposition.
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Background: The importance of extrapulmonary tuberculo-
sis (EPTB) among all forms of tuberculosis has not yet been
ascertained in developing countries. Multi drug resistant
tuberculosis (MDR-TB) is an increasing worldwide problem
aswell as in India. The transmission of resistance strains
is increasing day-by-day because of the rising load of
MDR-TB patients. The aim of the study to know incidence
of MDR-TB in extra pulmonary tuberculosis cases in tertiary
care hospitals in Northern India.
Materials and Methods: A total of 789 specimens
from patients of EPTB cases with varied presentation
were studied. All the samples were processed for
ZNStaining for Acid Fast bacilli and radiometric BACTEC
culture for Mycobacteria. Identiﬁcation of M. tuberculosis
complex (MTBC) was done by BACTEC NAP (p-nitro-a-
acetylamino-b-hydroxy propiophenone) differentiation test.
All M. tuberculosis isolates were recovered for radiometric
based drug susceptibility pattern against streptomycin,
isoniazid, rifampicin and ethambutol (SHRE) using the
proportion method.
Results: 165 (20.7%) of 797 patients clinically suspected
to have extra pulmonary tuberculosis were BACTEC culture
positive for mycobacteria. Out of 165 cases, 127 (77%)
were newly diagnosed and 38 (23%) previous treated
cases. On Biochemical characterization, 123 (74.5%) of the
164 isolates were identiﬁed as Mycobacterium tuberculosis
complex by NAP Test. A total of 123 (74.5%) M. tuberculosis
isolates for ﬁrstline antitubercular drug susceptibility
pattern. We observed that MDR strains (resistance to
rifampicin and isoniazid) were found in 15 (12.1%) of 123
isolates. Overall results shown that incidence of MDRTB in
EPTB case was 12.1%.
Conclusion: M. tuberculosis was present in 20.7 percent
samples. The maximum numbers of M. tuberculosis were
isolated from lymph node aspiration. Our study originates
that multi drug resistant tuberculosis is gradually increased
in extrapulmonary tuberculosis cases.
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identiﬁes two microRNAs as potential diagnostic
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Background: The biological behaviors and disease relevance
of microRNAs in the development of active tuberculosis
(ATB) are still unknown.
Methods: The expression proﬁle of microRNA under
the challenge of mycobacterium tuberculosis PPD was
ﬁrst measured using microarray in PBMCs isolated from
ATB patients and health controls (HC). The remarkably
reactive microRNAs were further validated in other cohorts
by quantitative real-time PCR (qRT-PCR). The receiver
operating characteristic (ROC) curve was plotted to evaluate
the diagnostic value of the determined PPD-responsive
microRNAs.
Result: It turned out that 14 out of 866 human microRNAs
showed signiﬁcantly higher increased expression after PPD
stimulation in ATB than in HC groups. The qRT-PCR study
validated the ﬁndings from microarray-based screen, in
which, upon PPD stimulation, miR-155 had fold change of
1.4 in HC group and 3.7 in ATB group (p < 0.0001); miR-155*
had 1.9 in HC and 4.6 in ATB group (p < 0.005). In ROC plots,
area under the curve (AUC) was 0.8972 for miR-155 and
0.7945 for miR-155*.
Conclusion: MiR-155 and miR-155* exhibited characteristic
expression by TB-speciﬁc antigen, suggesting that they can
be potential diagnostic markers under the challenge of
speciﬁc MTB antigens.
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Objective: QuantiFERON-TBGold (QFT-G) test is a recent
method in the diagnosis of latent or active tuberculosis and
shows better results. This assay based on the detection of
interferon-gamma; produced by stimulated T lymphocytes
with tuberculosis speciﬁc antigens. In this study we evaluate
the degree of usefulness of this method in detecting the
Pott’s disease.
Methods: A total of 83 cases were included in this study.
Among them few were conﬁrmed tuberculosis patients
as evidenced by the traditional clinical techniques like
Ziehl Nelsen smear, BACTEC culture, PCR IS6110 gene
and histopathology as well as they undergone surgery
for treatment. In this study nonsurgical cases were also
included, their conﬁrmation was done with the TB ELISA.
The above all cases were compared with the recent QFT-G
assay for its efﬁcacy, sensitivity and speciﬁcity in conﬁrming
the cases of both suspected and conﬁrmed tuberculosis.
Results: The study comprised of 83 cases, however 5cases
were excluded in this as they were found to be malignant.
Among the 52 surgical cases, it was found that 39 were
tested to be tuberculosis and 13 were found to be negative
by the traditional clinical techniques. However, the QFT-G
assay gives the result that among the 39 active tuberculosis
samples only 24 found to be positive. Interestingly, 1 has
given tuberculosis positive from the samples observed to
be negative by the traditional tests. Then, the sensitivity
and speciﬁcity was 62% and 92%, (p value = 0.001), 56%
and 100%, (p value = 0.009) surgical and nonsurgical
patient correspondingly. The overall 60% sensitivity and 95%
speciﬁcity (p value 0.001).
Conclusion: By analyzing the obtained results we can say
that the speciﬁcity of QFT-G was high but its sensitivity
